Transaction · 0001127602-25-006578

Guerrero Ramiro

Guerrero Ramiro, DIR, reported an open-market or private purchase at MAIA Biotechnology, Inc. involving 73333.000000 shares for an estimated $137132.71. Reported holdings after the transaction were 73333.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PDIR
MAIAMAIA Biotechnology, Inc.
Filing timeFeb 25
Trade dateFeb 24, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

MAIA price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
MAIA since 2025-02-25Filed 556 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
Buy
Code P
Identifier
0001127602-25-006578
Warrants
Transaction date
Feb 24, 2025
Filed Feb 25, 2025, 09:11 PM · 1d delay
Shares
73.3k sh
$187 per share
Estimated value
$13.7M
Computed from shares × price
Holdings after
73.3k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Buy Derivative Transaction Director Buy Direct Ownership Large Holdings Increase Repeat Buyer
+42score
Filing-only score

+42

Compact filing score computed from stored Form 4 facts. Version v1.

Strong filing signal

This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The common stock was purchased pursuant to a Securities Purchase Agreement and were isused under the Issuer's 2021 Equity Incentive Plan on February 24, 2024.

  2. F2

    These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on February 24, 2024. The options are exercisabl…

Original filing · 0001127602-25-006578
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

MAIA